From Surf Wiki (app.surf) — the open knowledge base
Olmesartan/hydrochlorothiazide
| Combination of |
|---|
| Angiotensin II antagonist |
| Thiazide diuretic |
| Benicar HCT, Benitec H, others |
| Micromedex Detailed Consumer Information |
| .mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0} |
| US DailyMed: Olmesartan hydrochlorothiazide |
| By mouth |
| C09DA08 (WHO) |
| US: ℞-only |
| 760190-74-7 |
| D10284 |
Olmesartan/hydrochlorothiazide, sold under the brand name Benicar HCT among others, is a fixed-dose combination medication used to treat high blood pressure. It is a combination of olmesartan medoxomil, an angiotensin II receptor blocker and hydrochlorothiazide, a diuretic. It may be used if olmesartan is not sufficient to manage blood pressure. It is taken by mouth.
Common side effects include nausea, dizziness, and upper respiratory tract infections. Serious side effects may include kidney problems, allergic reactions, electrolyte problems and low blood pressure. Use in pregnancy is not recommended. Olmesartan works by blocking the effects of angiotensin II while hydrochlorothiazide works by increasing the loss of sodium by the kidneys.
No generic version is available in the United States as of 2017. In 2022, it was the 235th most commonly prescribed medication in the United States, with more than 1 million prescriptions.
Ask Mako anything about Olmesartan/hydrochlorothiazide — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report